Barclays PLC Cerus Corp Transaction History

Barclays PLC

$854 Billion
Q3 2025

A detailed history of Barclays PLC transactions in Cerus Corp stock. As of the latest transaction made, Barclays PLC holds 1,120,927 shares of CERS stock, worth $1.82 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,120,927

Previous 1,421,220 21.13%

Holding current value

$1.82 Million

Previous $2.01 Million 11.12%

% of portfolio

0.0%

Previous 0.0%

33 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 12, 2025	SELL	$1.16 - $1.6 $348,339 - $480,468	-300,293 Reduced 21.13%	1,120,927 $1.78 Million
Q2 2025 Aug 13, 2025	BUY	$1.22 - $1.51 $37,750 - $46,723	30,943 Added 2.23%	1,421,220 $2.01 Million
Q1 2025 May 15, 2025	SELL	$1.39 - $2.15 $124,808 - $193,048	-89,790 Reduced 6.07%	1,390,277 $1.93 Million
Q4 2024 Feb 13, 2025	SELL	$1.52 - $2.03 $144,372 - $192,813	-94,982 Reduced 6.03%	1,480,067 $2.28 Million
Q3 2024 Nov 15, 2024	BUY	$1.7 - $2.39 $373,583 - $525,214	219,755 Added 16.21%	1,575,049 $2.74 Million

Q2 2024 Aug 14, 2024	SELL	$1.62 - $2.04 $105,849 - $133,291	-65,339 Reduced 4.6%	1,355,294 $2.39 Million
Q1 2024 May 15, 2024	SELL	$1.66 - $2.42 $277,945 - $405,197	-167,437 Reduced 10.54%	1,420,633 $2.69 Million
Q4 2023 Feb 15, 2024	BUY	$1.25 - $2.35 $224,683 - $422,405	179,747 Added 12.76%	1,588,070 $3.43 Million
Q3 2023 Nov 07, 2023	BUY	$1.5 - $3.07 $332,788 - $681,107	221,859 Added 18.7%	1,408,323 $2.28 Million
Q2 2023 Aug 03, 2023	BUY	$1.79 - $2.9 $948,567 - $1.54 Million	529,926 Added 80.72%	1,186,464 $2.92 Million
Q1 2023 May 04, 2023	BUY	$2.65 - $3.81 $1.5 Million - $2.15 Million	565,549 Added 621.56%	656,538 $1.95 Million
Q4 2022 Feb 13, 2023	BUY	$3.38 - $4.22 $171,906 - $214,629	50,860 Added 126.74%	90,989 $331,000
Q3 2022 Nov 03, 2022	SELL	$3.43 - $5.83 $97,195 - $165,204	-28,337 Reduced 41.39%	40,129 $143,000
Q2 2022 Aug 12, 2022	BUY	$4.41 - $5.69 $3,413 - $4,404	774 Added 1.14%	68,466 $362,000
Q1 2022 May 16, 2022	SELL	$4.81 - $6.99 $815,905 - $1.19 Million	-169,627 Reduced 71.48%	67,692 $372,000
Q4 2021 Feb 14, 2022	BUY	$5.97 - $7.93 $767,604 - $1.02 Million	128,577 Added 118.24%	237,319 $1.62 Million
Q3 2021 Nov 09, 2021	BUY	$4.79 - $6.68 $267,013 - $372,369	55,744 Added 105.18%	108,742 $663,000
Q2 2021 Aug 13, 2021	SELL	$5.35 - $6.35 $450,887 - $535,165	-84,278 Reduced 61.39%	52,998 $313,000
Q1 2021 May 13, 2021	BUY	$5.68 - $7.87 $256,162 - $354,929	45,099 Added 48.93%	137,276 $825,000
Q4 2020 Feb 11, 2021	SELL	$5.25 - $8.56 $210,010 - $342,417	-40,002 Reduced 30.26%	92,177 $637,000
Q3 2020 Nov 12, 2020	BUY	$5.78 - $7.47 $14,149 - $18,286	2,448 Added 1.89%	132,179 $827,000
Q2 2020 Aug 12, 2020	BUY	$4.5 - $7.02 $196,879 - $307,132	43,751 Added 50.89%	129,731 $855,000
Q1 2020 May 13, 2020	SELL	$2.87 - $5.49 $237,966 - $455,203	-82,915 Reduced 49.09%	85,980 $400,000
Q4 2019 Feb 10, 2020	BUY	$3.84 - $4.86 $343,591 - $434,858	89,477 Added 112.67%	168,895 $712,000
Q3 2019 Nov 14, 2019	SELL	$4.86 - $6.05 $92,028 - $114,562	-18,936 Reduced 19.25%	79,418 $409,000
Q2 2019 Aug 14, 2019	BUY	$4.51 - $6.6 $213,665 - $312,681	47,376 Added 92.93%	98,354 $553,000
Q1 2019 May 15, 2019	BUY	$5.16 - $6.85 $184,537 - $244,976	35,763 Added 235.05%	50,978 $318,000
Q4 2018 Feb 14, 2019	SELL	$4.89 - $7.16 $780,199 - $1.14 Million	-159,550 Reduced 91.29%	15,215 $77,000
Q3 2018 Nov 14, 2018	SELL	$6.89 - $7.78 $700,175 - $790,619	-101,622 Reduced 36.77%	174,765 $1.26 Million
Q2 2018 Aug 14, 2018	SELL	$5.19 - $7.25 $64,335 - $89,871	-12,396 Reduced 4.29%	276,387 $1.84 Million
Q1 2018 May 15, 2018	BUY	$3.56 - $5.74 $46,714 - $75,320	13,122 Added 4.76%	288,783 $1.58 Million
Q4 2017 Feb 14, 2018	BUY	$2.76 - $3.95 $331,950 - $475,074	120,272 Added 77.4%	275,661 $932,000
Q3 2017 Nov 14, 2017	BUY	$2.22 - $2.73 $344,963 - $424,211	155,389	155,389 $425,000

Others Institutions Holding CERS

# of Institutions

167

Shares Held

135M

Call Options Held

126K

Put Options Held

30.1K

View Full List

About CERUS CORP

Ticker CERS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 177,090,000
Market Cap $287M
Description
Cerus Corporation operates as a biomedical products company. The company focuses on developing and commercializing the INTERCEPT Blood System to enhance blood safety. Its INTERCEPT Blood System, a proprietary technology for controlling biological replication that is designed to reduce blood-borne pathogens in donated blood components intended fo...

More about CERS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Account